Stock info Swedish Orphan Biovitrum | Filter  Basic-Info

Stock: Swedish Orphan Biovitrum (Sweden large caps), ISIN: SE0000872095

Last Price 270.80 Max Price 292.80
Min Price 200.00 1 Year return 46.30
Sector Health Care Subsector Health Care Eq. & Services

Loading...

Contact info:Street: Tomtebodavagen 23APostbox: 112 76City: SolnaCountry: SwedenPhone: 46-8-6972000Website: www.sobi.comCEO: Geoffrey McDonoughCFO: MatsOlof Wallin

Sector Review Swedish Orphan Biovitrum

Loading...
Year Turnover Total sector Market share
2019 14,248 2,019,627 0.71 %
2020 15,261 2,170,562 0.70 %
2021 15,529 2,404,921 0.65 %
2022 18,790 2,645,840 0.71 %
2023 0 0 0.00 %

Advice Swedish Orphan Biovitrum

No Records Found




News Swedish Orphan Biovitrum

No Records Found

Annual reports Swedish Orphan Biovitrum

No Records Found


Profile Swedish Orphan Biovitrum

Swedish Orphan Biovitrum

(SE0000872095)

The past year was a good year for Swedish Orphan Biovitrum investors

Over the last 12 months (from December 2015 till December 2016), that were loss-making period for the investors in Swedish Orphan Biovitrum, the stock lost around 19 percent. Over the period from December 2011 till December 2016 the stock rose on average 744 percent. Swedish Orphan Biovitrum's revenues between 2011 and 2015 were quite unstable and moved between 1,92 billion SEK and 3,23 billion SEK. Swedish Orphan Biovitrum's net incomes between 2011 and 2015 were quiet stable and moved between 68,98 million SEK and 68,39 million SEK.

Swedish Orphan Biovitrum's main office is based in Solna. The period from 2006 till the end of 2016 the international sector gained around 102 percent. As from 2011 the sector is 64 percent higher and over the past 12 months (December 2015-December 2016) there is a plus of 102 percent.

The Swedish company didn't pay out any dividends (in the past 5 years).

Swedish Orphan Biovitrum' balance mostly consists of equity

At the end of 2015 the Swedish company's balance sheet was worth 8,31 billion SEK. Of the total balance sheet 8,31 billion SEK (100 percent) was financed by debt. Last year the health care company's price/earnings-ratio (PE) was around 304. So the investors valued the stock at 304 times 2015' earnings per share. Many analysts say that based on her price/earnings-ratio and dividend yield the Swedish stock can be seen as a growth stock.

The health care company's market capitalization (the number of shares outstanding times the market value) equaled around 35,36 billion SEK. At the end of 2015 the Swedish company had around 267,28 million stocks listed.

At this page you find all Swedish Orphan Biovitrum's financial reports. More information about Swedish Orphan Biovitrum can be found it's website. .


Results Swedish Orphan Biovitrum

Results
2015
2016
2017
2018
2019
2020
Revenue
3,228
4,496
6,511
9,139
14,248
15,261
Costs
3,163
3,695
5,362
6,721
10,944
12,016
Profit
65
801
1,149
2,418
3,304
3,245
Margin of profit
2.01
17.81
17.64
26.46
23.19
21.26
ROI
1.39
14.93
17.14
26.75
19.52
16.06

Balance Swedish Orphan Biovitrum

Balance
2015
2016
2017
2018
2019
2020
Equity
4,660
5,365
6,701
9,040
16,930
20,206
Debt
3,655
4,609
4,202
8,143
28,728
28,077
Total assets
8,315
9,974
10,903
17,183
45,658
48,283
Solvency
56.05
53.79
61.46
52.61
37.08
41.85
Cash
904
786
1,479
2,999
737
404
Cashflow
507
343
1,333
2,090
3,634
4,926
Employees
0
0
0
0
0
Revenue per employee
0.0
0.0
0.0
0.0
0.0
Cashflow / Debt
0.14
0.07
0.32
0.26
0.13
0.18

Details Swedish Orphan Biovitrum

Details
2016
2017
2018
2019
2020
Price
134.60
106.70
112.30
193.00
154.50
Eps
2.98
4.25
8.93
11.22
10.90
Price/earnings-ratio
45.17
25.11
12.58
17.20
24.84
Dividend
0.0
0.0
0.0
0.0
Dividend %
0.00 %
0.00 %
0.00 %
0.00 %
Payout %
0.0
0.0
0.0
0.0
Book value
19.96
24.89
33.49
57.53
68.52
Market to book
0.15
0.23
0.30
0.30
0.25
Cashflow per stock
1.28
4.95
7.74
12.35
16.70
Stocks
269
269
270
294
295
Market Cap
36.177.74
28.729.81
30.309.55
56.799.90
79.858.11

Dividend Swedish Orphan Biovitrum


Price info Swedish Orphan Biovitrum

Date
Price
22 Mar 2024
270.80
18 Mar 2024
267.80
15 Mar 2024
276.20
12 Mar 2024
280.20
11 Mar 2024
280.80
09 Mar 2024
280.80
07 Mar 2024
269.80
01 Mar 2024
254.60
29 Feb 2024
253.40
27 Feb 2024
256.80
22 Feb 2024
264.80
21 Feb 2024
263.20
20 Feb 2024
260.00
15 Feb 2024
250.40
14 Feb 2024
252.60
13 Feb 2024
252.40
09 Feb 2024
259.40
08 Feb 2024
259.40
07 Feb 2024
282.00
06 Feb 2024
274.20
05 Feb 2024
272.00
01 Feb 2024
292.00
31 Jan 2024
292.00
30 Jan 2024
291.00
27 Jan 2024
286.80
25 Jan 2024
290.80
24 Jan 2024
285.20
23 Jan 2024
292.80
16 Jan 2024
286.00
11 Jan 2024
279.60